Loading...
XSHE
300896
Market cap3.83bUSD
Jul 09, Last price  
85.89CNY
1D
-1.14%
1Q
-25.30%
IPO
-54.82%
Name

Imeik Technology Development Co Ltd

Chart & Performance

D1W1MN
XSHE:300896 chart
P/E
20.13
P/S
10.72
EPS
4.27
Div Yield, %
5.82%
Shrs. gr., 5y
-0.09%
Rev. gr., 5y
10.85%
Revenues
2.42b
-19.89%
75,124,088111,817,498140,732,063222,489,964321,011,015557,715,652709,290,1971,447,872,0011,447,872,0001,938,838,3631,938,838,3632,869,347,2313,025,668,4482,423,833,830
Net income
1.29b
-34.05%
28,419,40717,652,01453,377,01982,193,513122,854,846305,519,844439,748,789957,979,585957,979,5891,263,558,4151,263,558,4201,858,475,3061,957,596,8341,291,017,682
CFO
1.39b
-28.04%
27,949,80048,345,80054,997,80084,158,823135,496,573309,715,080425,677,596942,779,5081,193,935,2031,954,070,6431,927,174,5231,386,791,180
Dividend
Sep 26, 20251.2 CNY/sh

Notes

No notes on this company yet
Write a private note on this company, for your eyes only

Profile

Imeik Technology Development Co.,Ltd. specializes in the research, development, manufacturing, and distribution of biomedical materials. The company's diverse product portfolio caters to both the medical aesthetics field and general skincare needs. Within its medical beauty offerings, Imeik provides a range of recognized brands including Moisten Angel, IFRESH, Yimei, Hearty, Bonita Bonita, and Tightly. Additionally, its comprehensive skincare line features hydrating lotions, anti-aging and firming serums, concentrated essence creams, revitalizing facial masks, restorative chitosan B5 sprays, and clarifying and illuminating liquids. Established in 2004, the company's operations are based in Beijing, China.
IPO date
Sep 28, 2020
Employees
Domiciled in
CN
Incorporated in
CN

Valuation

Title
CNY in thousands, except ratios and share amounts
FYFYFYFYFYFYFYFYFYFYFYFY
2025‑122024‑122023‑122023‑002022‑122022‑002021‑122020‑122019‑122018‑122017‑122016‑12
Income
Revenues
Cost of revenue
Unusual Expense (Income)
NOPBT
NOPBT Margin
Operating Taxes
Tax Rate
NOPAT
Net income
Dividends
Dividend yield
Proceeds from repurchase of equity
BB yield
Debt
Debt current
Long-term debt
Deferred revenue
Other long-term liabilities
Net debt
Cash flow
Cash from operating activities
CAPEX
Cash from investing activities
Cash from financing activities
FCF
Balance
Cash
Long term investments
Excess cash
Stockholders' equity
Invested Capital
ROIC
ROCE
EV
Common stock shares outstanding
Price
Market cap
EV
EBITDA
EV/EBITDA
Interest
Interest/NOPBT